Membrane proteome functional characterization of breast cancer-initiating cells subjected to bone morphogenetic protein signaling inhibition by dorsomorphin

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Susy Piovesana
  • Anna Laura Capriotti
  • Valentina Colapicchioni
  • Francesca Ferraris
  • La Barbera, Giorgia
  • Salvatore Ventura

In this study, A17 cells, which are an invasive mesenchymal cell line with cancer stem cell properties, were exploited for the study of the role of bone morphogenetic protein pathways in cancer-initiating cells employing a proteomics-based approach. A17 cells were treated with the bone morphogenetic protein signaling inhibitor dorsomorphin for 3 days. After that, subcellular fractionation of cell samples was performed and the membrane fraction analyzed by shotgun proteomics. The extracted membrane proteins were enzymatically digested and the resulting peptide mixture was analyzed by nano liquid chromatography coupled to tandem mass spectrometry and relative label-free quantitation. Protein profiles of A17 membrane fractions before and after dorsomorphin treatment were compared, and further mined by Gene Ontology search. The protein profile of untreated A17 samples correlated with the mesenchymal phenotype, whereas changes were observed in dorsomorphin-treated samples, further supporting a mesenchymal to epithelial transition upon bone morphogenetic protein signaling pathway inhibition and the importance of this pathway in breast cancer cell malignancy.

OriginalsprogEngelsk
TidsskriftMedicinal Chemistry Research
Vol/bind25
Udgave nummer9
Sider (fra-til)1971-1979
Antal sider9
ISSN1054-2523
DOI
StatusUdgivet - 1 sep. 2016

ID: 231312018